E Fund Management Co., Ltd. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
E Fund Management Co., Ltd. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$382
-9.3%
12,075
+16.9%
0.03%
-12.1%
Q2 2023$421
+4.7%
10,330
-4.2%
0.03%
+13.8%
Q1 2023$402
+3.9%
10,782
-2.9%
0.03%
-9.4%
Q4 2022$387
-99.9%
11,103
+50.2%
0.03%
-17.9%
Q3 2022$414,000
-22.5%
7,393
-28.3%
0.04%
-18.8%
Q2 2022$534,000
+67.9%
10,315
+135.7%
0.05%
+380.0%
Q1 2022$318,0004,3770.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders